Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

King Pharmaceuticals reports 1Q loss
Yahoo/AP
Monday, May 11, 2009 - 8:42am
tags:
King, earnings
Neurobiological Tech Provides an Exit Opportunity
Seeking Alpha
Monday, May 11, 2009 - 8:40am
tags:
Neurobiological Tech
AstraZeneca shares leap after its drug beats Plavix in test
Yahoo/Reuters
Monday, May 11, 2009 - 8:37am
tags:
AstraZeneca, Sanofi, Plavix, Brilinta, Bristol-Myers Squibb
Eisai Rises as Company Says It Can End Pfizer Pact
Bloomberg
Monday, May 11, 2009 - 8:36am
tags:
Eisai, Aricept, Pfizer
Amylin: Icahn's Proxy Damning for Management
Seeking Alpha
Monday, May 11, 2009 - 8:32am
tags:
Amylin, Carl Icahn
Will New Results on Merck and GSK's HPV Vaccines Ignite Sales Growth?
Seeking Alpha
Monday, May 11, 2009 - 8:30am
tags:
Merck, GSK, Cervarix, vaccines, Gardasil, HPV
Semi-Annual Changes to the NASDAQ Biotechnology Index
Yahoo
Saturday, May 9, 2009 - 12:57pm
tags:
biotech
The great risk of regulated drug prices
Fosters
Saturday, May 9, 2009 - 12:55pm
tags:
Gilead Sciences Thumped by Drug Data
The Street
Saturday, May 9, 2009 - 12:44pm
tags:
Gilead Sciences, darusentan
FDA notes side effects with Genentech cancer drug
Yahoo
Saturday, May 9, 2009 - 12:42pm
tags:
Genentech, Tarceva
"Stress tests" stoke drug stocks, broader market
MarketWatch
Saturday, May 9, 2009 - 12:41pm
tags:
biotech
Incyte Q1 2009 Earnings Call Transcript
Seeking Alpha
Saturday, May 9, 2009 - 12:29pm
tags:
Incyte
Small-Cap Biotechs: How to Separate The Contenders From The Pretenders
Seeking Alpha
Saturday, May 9, 2009 - 12:27pm
tags:
biotech
Vioxx class action suit in California rejected
Yahoo
Saturday, May 9, 2009 - 12:26pm
tags:
Vioxx
Glaxo Goes Head-to-Head on HPV
Motley Fool
Saturday, May 9, 2009 - 12:25pm
tags:
GSK
Investing Against Breast Cancer
Motley Fool
Saturday, May 9, 2009 - 12:24pm
tags:
breast cancer
Taking A Shot At GlaxoSmithKline
CNBC
Saturday, May 9, 2009 - 12:20pm
tags:
GSK
Somaxon - Too Much Risk
Yahoo/Zacks.com
Friday, May 8, 2009 - 11:36am
tags:
Somaxon, Silenor
"Stress tests" stoke drug stocks, broader market
Marketwatch
Friday, May 8, 2009 - 11:31am
tags:
drug stocks
4-Star Stocks Poised to Pop: Bristol-Myers
Motley Fool
Friday, May 8, 2009 - 11:30am
tags:
Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.